was repeated, yielding identical N-terminal sequences of DIQGHKAGD, and the sequence was used to search a release of P. aeruginosa genomic sequences (http://www. pseudomonas.com). This identified a single homologous open reading frame encoding a pre-protein with a predicted 22 amino acid signal sequence, followed by a peptide of 210 amino acids that included the above N-terminal sequence as the first nine amino acids. This sequence (Figure) was found in contig 216 (from bases 51,972 to 51,277 on the complementary strand; 15 September 1998 release of genomic sequences), located at about 1000 kbp on the physical genomic map on macrorestriction fragment DpnI-L, SpeI-A (http://www.bit.uq.edu.au/pseudomonas/ map.html).
The predicted 210 amino acid protein is 43% identical and 58% similar to a Vibrio cholerae OMP, OmpW 6 ( Figure) , which is itself a member of a family of minor OMPs that are predicted to form eight-stranded -barrels. 7 Two of the closer homologues, DoxH 8 and AlkL, 9 are encoded in operons involved in naphthalene and alkane catabolic pathways respectively, but their precise functions are not known.
In conclusion, we have identified and sequenced the last of the P. aeruginosa major OMPs. This will permit further studies to determine its cellular function and potential role in quinolone uptake. Sir, Many clinically important Gram-negative bacteria possess effective outer membrane (OM) permeability barriers that markedly limit the penetration and, thus, the activities of hydrophobic antibiotics, such as erythromycin and rifampicin, and large antibiotic molecules, such as vancomycin. 1, 2 This, in part, explains why these pathogens are resistant to most of the recently discovered agents (e.g. the oxazolidinones and everninomicin) that exhibit potent activities against Gram-positive bacteria. 3 The barrier function of the OM relies principally on the compact leaflet of lipopolysaccharide (LPS) molecules that covers the cell surface and which is fairly impermeable to hydrophilic and (moderately) hydrophobic compounds. This is exemplified by the recently described Escherichia coli mutants, l p x A and l p x D, in which the lipid A moieties of the LPS have undergone profound alterations and which are almost as susceptible to hydrophobic antibiotics as the Gram-positive reference strains. 3, 4 The MICs of a large number of antibiotics for the E. coli lpxA mutant are 30-to 1000-fold lower than those for clinical isolates of E. coli. 4 Other LPS mutants, such as those in which the inner core polysaccharide moieties of the LPS are defective (Re type), also exhibit antibiotic supersusceptibility, although to a lesser extent than the lipid A mutants.
The most reliable method of quantifying the permeability of the OM to hydrophobic compounds is that developed by Plésiat & Nikaido 5 which allows the rates of penetration of various steroid probes across the lipid portion of the bilayer to be accurately determined. The results are expressed in terms of the permeability coefficient (P) in nanometres per second (nm/s). With this approach, these investigators showed that the OM of a Re mutant of Salmonella typhimurium was up to 25-and 16-fold more permeable to uncharged steroids and to testosterone hemisuccinate (a monoanionic probe) respectively than that of the parent strain.
5 P values for the most antibiotic-hypersusceptible strains, i.e. the lipid A mutants, have not yet been reported. In the present study, we demonstrate that the diffusion rate of testosterone hemisuccinate through the lpxA-type OM is much higher than that through the Re-type OM.
The strains used in the study were as follows: the lipid A mutants of E. coli SM101 (lpxA) and E. coli CDH23-213 (lpxD, the gene formerly known as omsA, firA and ssc), both of which are thermosensitive, i.e. SM101 grows well at 28°C, but not at 37°C, and CDH23-213 grows well at 20°C and 37°C, but not at 42°C; the corresponding isogenic parent-type strains, SM105 (lpxA ) and CDH23-210 (lpxD ), which were used as controls; and the E. coli mutant strain, D21f2 (rfa), which has a defective inner core oligosaccharide and which elaborates Re-type (heptoseless) LPS. The antibiotic susceptibilities of all of the strains have been characterized previously. 3, 4 The study strains were transformed with the recombinant plasmid, pLE689, that mediates the 3-oxosteroid 1 -dehydrogenase enzyme of Comamonas testosteroni. 5 The media used were LB agar and broth, both containing 10 g of tryptone (Oxoid, Basingstoke, UK), 5 g of yeast extract (Difco, Detroit, MI, USA) and 5 g of NaCl, at pH 7.2, and supplemented with kanamycin at a concentration of 25 mg/L. The agar plates and broth cultures were incubated at 30°C. The steroid permeability assay was performed as described previously. 6 Briefly, cells in the exponential growth phase were collected by centrifugation at room temperature and resuspended in 50 mM HEPES, pH 7.4, to an A 650 of 3. Tubes containing 700 L of bacterial suspension diluted three-, six-or 30-fold in the same buffer were incubated at 30°C with gentle agitation. The neutral steroid, t e s t o s t e r o n e , or its hemisuccinate derivative was added at time 0 to give final concentrations of 50 M and 200 M respectively. Following incubation for 10 min, 95% of the steroid was removed by two brief extractions with ethyl acetate. The concentration of the -dehydrogenated product was then determined by high-performance liquid chromatography (HPLC) and the permeability coefficients were calculated according to an equation based on Ficks' First Law of Diffusion. 6 The P values for testosterone hemisuccinate in the lipid A mutants, SM101 (lpxA) and CDH23-213 (lpxD), were approximately 900-1100 nm/s-approximately five-to six-fold greater than that in the E. coli Re mutant, D21f2 (Table) , approximately ten-fold greater than that previously determined in the Re mutant of S. typhimurium (data not shown) and approximately 50-to 100-fold greater than those in the control strains (Table) . Of considerable note, the high P values for the lipid A mutants demonstrated here are comparable to that (approximately 1000 nm/s) previously determined for the wild-type strain, S. typhimurium SL696, 5 following exposure to deacylpolymyxin B (DAPB), a potent permeabilizer of the OM. 7 This suggests that the OM permeability barrier to a representative anionic hydrophobic probe molecule is quantitatively equally defective in both the lipid A mutants and the DAPB-permeabilized cells.
The P values for testosterone in the lipid A mutants (3260 nm/s and 4270 nm/s in CDH23-213 and SM101, respectively) were similar to that (3620 nm/s) in the Re mutant ( Table) . This suggests that the Re-type OM is already maximally permeable to this neutral hydrophobic probe. In accord with this observation, previous investigators have shown that the P coefficient for another uncharged steroid, androstanedione, in DAPB-treated S. typhimurium was comparable to that in the Re mutant of S. typhimurium. 5 Studies such as the one described here add to our knowledge of the properties of the permeability barriers of mutationally defective OMs. This in turn provides information that might help in designing novel antibiotics with activities against Gram-negative bacteria. In the light of increasing antibiotic resistance worldwide, such agents are needed desperately. Sir, The bacterial composition of the subgingival flora varies widely from individual to individual and from pocket to pocket in the same individual. Certain pathogens, particularly Prevotella intermedia, are associated with severe forms of periodontal disease. 1 Not all patients respond equally to periodontal treatment and antibiotics can enhance the effects of surgical intervention in those with rapidly progressive or refractory periodontitis. 2 One of the most frequently prescribed antibiotics is metronidazole, resistance to which is rarely encountered, although treatment with high dosages may be necessary to eradicate some pathogens. In common with the causes of infection at other sites, periodic surveys of the susceptibilities of the aetiological agents of periodontitis are necessary in order to detect changes in the patterns of resistance and thereby to facilitate optimal antibiotic therapy. The present study was undertaken to determine the in-vitro susceptibilities of P. intermedia isolates to metronidazole and to evaluate the efficacy of the Etest for this purpose.
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Subgingival plaque samples were obtained from patients with periodontitis and inoculated on to solid medium within 3 h; the plates were incubated under anaerobic conditions at 37 C for 3-7 days. Isolates of P. intermedia (n 1 3 ) were identified according to standard laboratory procedures. Susceptibility to metronidazole was determined by an agar dilution method recommended by the NCCLS 3 and by the Etest method (AB Biodisk, Solna, Sweden) according to the manufacturer's instructions. The medium in both cases was Columbia agar (bioMérieux, Marcy l'Etoile, France) supplemented with 10% sheep blood, haemin (5 mg/L) and menadione (0.5 mg/L), and the inoculum for the agar dilution method was 10 5 cfu. P. intermedia isolates CIP 103607 and CIP 6322 (Collection of the Pasteur Institute, Paris) were used as controls and all plates were incubated for 48 h at 37 C in an anaerobic chamber.
The mean MIC for the 13 isolates, as determined by the reference agar dilution method, was 0.98 mg/L (range 0.25-2 mg/L), whereas the mean MIC determined by the Etest was 0.82 mg/L (range 0.047-2 mg/L). In 33% of cases, the MICs determined by the two methods were the same. Of the remaining isolates, the MICs for 87% and 93% were within one and two two-fold dilutions, respectively. For only one strain was the difference between the MICs determined by the two methods more than four two-fold dilutions (MIC of 0.047 mg/L with the Etest and 0.25 mg/L with the agar dilution method).
We have shown in the present study that the MICs of metronidazole for clinical isolates of P. intermedia are broadly similar, regardless of whether they are determined by the Etest or the agar dilution method; 93% of results differed by no more than two two-fold dilutions. Others have reported similar results, i.e. concordance or a difference of only one or two two-fold dilutions in 34.3%, 74% and 90% of strains, respectively. 4 We conclude that the Etest is a simple, rapid and reliable method of determining the MICs of metronidazole for P. intermedia isolates. However, its relatively high cost will preclude it from being used as a routine susceptibility testing method.
The MIC 1 0 0 of metronidazole for the 13 isolates (2 mg/L), based on MICs determined by the agar dilution method, is in agreement with the susceptibility data reported by other i n v e s t i g a t o r s 5 , 6 and is less than the MIC breakpoint (8 mg/L) recommended by the NCCLS. 3 The highest MIC recorded by us, 2 mg/L, was one two-fold dilution higher than that reported by Sutter et al. 6 However, those investigators included isolates other than P. intermedia and did not distinguish one black pigmented species from another.
Although only a small number of isolates were evaluated, the present study demonstrates the excellent in-vitro activity of metronidazole against P. intermedia, with 100% of the isolates tested being susceptible to this agent on the basis of the recommended MIC breakpoint. This observation is in accord with multicentre studies in the USA which determined the susceptibilities of much larger numbers of isolates, and confirms that the isolation of a strain belonging to this species that exhibits resistance to metronidazole is a very rare event.
of the pathogens), followed by CoNS (24%), although the roles of these organisms as causes of acute conjunctivitis are controversial. The susceptibilities of the isolates are summarized in the Table. The ranking of the antibiotics in terms of percentage susceptible strains (in descending order) was as follows: bacitracin; gentamicin; ciprofloxacin; tobramycin; lomefloxacin; chloramphenicol; trimethoprim/ sulphamethoxazole; neomycin; tetracycline; erythromycin; and penicillin. While chloramphenicol is the most commonly used ophthalmic antibiotic in Bangladesh, followed by ciprofloxacin and gentamicin (S. Hossain, personal communication), it was active against fewer isolates than the latter two drugs. Ciprofloxacin was active against a marginally higher percentage of isolates than lomefloxacin and, of the aminoglycosides tested, gentamicin was active against the highest percentage of strains.
The results of this study are in accord with published data from Pakistan 3 which also showed that bacitracin was the most active antibiotic tested (91% of isolates being susceptible); moreover, the percentages of strains that were susceptible to tetracycline, chloramphenicol, gentamicin and neomycin were comparable to those reported here. Whilst the absence of comprehensive published data concerning the antibiotic susceptibilities of ocular pathogens precludes drawing accurate conclusions about trends in susceptibility/resistance, the results of this limited study suggest that no currently available topical formulation is active in vitro against all of the common pathogens. Only one antibiotic combination, trimethoprim/sulphamethoxazole, was evaluated by us and this agent was not superior to the single antibiotics tested. In conclusion, we have demonstrated that bacitracin is the most broad-spectrum agent currently available in Bangladesh as empirical treatment of patients with external ocular infections.
